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In some species of growing mammals glutamine is an essential amino acid 
that, if inadequate in the diet, is needed for normal growth and develop-
ment. It is thus sometimes considered to be a conditionally essential amino 
acid in some species. A review of studies that have measured L-glutamine 
concentrations ([glutamine]) in horses demonstrates that plasma [glutamine] 
has routinely been reported to be much lower (~330 µmol/L) than in oth-
er mammals (> 600 µmol/L). Plasma [glutamine] represents the balance 
between intestinal transport into the blood after hepatic first pass, tissue 
synthesis and cellular extraction. The hypothesis is proposed that sustained 
low plasma [glutamine] represents a chronic state of sub-optimal glutamine 
intake and glutamine synthesis that does not meet the requirements for op-
timum health. While this may be without serious consequence in feral and 
sedentary horses, there is evidence that provision of supplemental dietary 
glutamine ameliorates a number of health consequences, particularly in 
horses with elevated metabolic demands. The present review provides evi-
dence that glutamine is very important (and perhaps essential) for intestinal 
epithelial cells in mammals including horses, that horses with low plasma 
[glutamine] represents a sub-optimal state of well-being, and that horses 
supplemented with glutamine exhibit physiological and health benefits.
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1. Introduction
Glutamine is an important metabolite involved in gluconeogenesis, lipolysis, antioxidant defense, the production of nitric oxide, the secretion of 
peptides (e.g. glucagon-like peptide 1, GLP-1), neurome-
diators, the regulation of cell growth, regulation of cellu-
lar function and cell / tissue regeneration [1-5]. The impor-
tance of glutamine in numerous cellular processes, and the 
fact that plasma concentrations ([glutamine]) appears to 
be quite low (by ~50%) in most horses studied compared 
to other mammals, suggests that dietary glutamine may 
be inadequate in many horses. Unfortunately, the dietary 
requirement for glutamine has been considered only with 
respect to protein synthesis. However dietary glutamine 
requirements also need to be considered with respect to 
its numerous other functions in the body. For example, 
in other species inadequate glutamine is associated with 
increased incidence and severity of respiratory disease [6], 
brain disorders [7], type 1 diabetes [5], slowed muscle gly-
cogen synthesis [4], impaired gut morphology and health [8-
11] and impaired immune health [12,13]. 
The purposes of this review are to report the concentra-
tions of glutamine in equine plasma and muscle in studies 
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published in the past 50 years and to use a comparative 
physiology approach to demonstrate that dietary gluta-
mine ingestion appears to be low in most horses studied, 
and perhaps in the general horse population. Some of the 
equine studies reviewed herein have already suggested 
that horses may benefit from dietary glutamine supple-
mentation. Many amino acids, including glutamine, are 
ingested in proteins and peptides as well as free amino ac-
ids as part of the normal diet. Some amino acids (glutamine 
for example) can be synthesized within the body, while 
others cannot. The ability to synthesize certain amino ac-
ids varies by species and developmental stage. In horses, 
except for lysine, the dietary requirements for amino acids 
have not been defined. The recommended protein intake [14] 
may provide adequate amino acids for protein synthesis 
related to growth and development, however recent stud-
ies have reported that the dietary supply of some amino 
acids may be in inadequate. With respect to protein syn-
thesis, these amino acids now include lysine [15], threonine 
[15,16] and methionine [17].
Under normal conditions, the body appears to attempt 
to meet glutamine demand primarily by de novo synthesis 
(Figure 1) from endogenous glutamate and branched-chain 
amino acids within tissues such as skeletal muscle [18-21], 
liver [18] and placenta [19]. Plasma [glutamine] is therefore 
the result primarily of tissue glutamine synthesis and tis-
sue glutamine extraction [3,20], and secondarily of dietary 
intake especially in the first few hours after meal ingestion 
[22-24]. During periods of increased metabolism (exercise, 
gestation, lactation) a state of protein catabolism often oc-
curs [18,19,22,25]. The sustained or increased tissue glutamine 
demand and metabolism during these states are associated 
with reduced plasma [glutamine] (Table 1). Under these 
conditions glutamine has been termed a “conditionally es-
sential” amino acid [2,3,8,12,26,27].
2. Importance of glutamine
The term glutamine will be used to refer specifically to 
L-glutamine, one of twenty amino acids that are used to 
build proteins under the guidance of the genetic codes. 
Glutamine exists in two zwitterionic forms, L-glutamine 
and D-glutamine. Because both the amino and carboxyl 
groups are attached to the first (alpha, α) carbon, gluta-
mine is classified as an α-amino acid. Glutamine is also 
neutral, i.e., it possesses no electrical charge. Glutamine is 
additionally the amide of glutamic acid, another naturally 
occurring amino acid, and is involved in various metabol-
ic activities including the formation of glutamate, and the 
synthesis of proteins, nucleotides and amino sugars.
The total amount of glutamine in the body is approxi-
mately 400 g in adult horses [18]. Glutamine plays import-
ant roles within intestinal tissues and skeletal muscle, and 
the body as a whole, including regulation of cellular gene 
expression, neuronal excitability, protein turnover, cellular 
metabolism, immunity and acid-base balance [27-29]. The 
amino acids glutamine and glutamate make up 10-20% of 
dietary protein, and both are extensively metabolized in 
the small intestine of most mammals. Watford [30] asserts 
that, with normal levels of dietary intake (5 - 10 g of glu-
tamine daily for humans), there is no net small-intestinal 
absorption of glutamine or glutamate into the blood, such 
that body’s glutamine pool results from de novo synthesis, 
primarily within skeletal muscle. In various mammals, in-
cluding humans, about 20% of dietary glutamine may end 
up in the systemic circulation, but this is dependent on 
the amount of glutamine ingested and the metabolic state. 
Therefore the high requirement for glutamine by intestinal 
enterocyte and immune cells result in considerably less 
glutamine entering the systemic circulation than what is 
ingested.
There is now good evidence that glutamine, and some 
other non-essential amino acids, are not synthesized in 
sufficient amounts during periods of increased metabol-
ic rate to support fetal development, neonatal growth, 
growth during lactation and as needed to maintain optimal 
vascular health, intestinal health and immune function in 
adult animals [27]. These amino acids have therefore been 
re-classified as “conditionally essential” [2,31] or “function-
al” amino acids (FAAs) because of their inadequacy in 
the diet, particularly in young and gestating mammals and 
during normal periods of increased metabolism such as 
during exercise and physical training. Inadequate intake 
of FAAs leads to functional deficits due to impairments 
in the regulation of key metabolic pathways involved 
in health, growth, development, reproduction and lacta-
tion [10,28,30,32]. Fürst et al. [33] characterized glutamine as a 
“conditionally indispensable amino acid during stress”, 
where stress is the commonly-used physiological term to 
describe the normal physiological responses that result in 
elevated metabolism.
Glutamine should be considered to be a “conditionally 
essential” α-amino acid that is nutritionally important for 
many animals including horses and humans, particularly 
during periods in which the metabolic state of the animal 
is normally elevated, such as during normal exercise, 
gestation, lactation, growth and development [2]. Supple-
mentation of FAAs such as glutamine, in amounts ade-
quate to meet nutritional and metabolic requirements, has 
been proposed [2,8] as a nutritional strategy to maintain or 
improve health, growth and development and to prevent 
diseases. Xi et al. [28] reported that adequate, high concen-
trations of intracellular and extracellular glutamine are 
DOI: https://doi.org/10.30564/vsr.v2i1.1619
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associated with marked reductions in infection, sepsis, 
severe burn, cancer, and other pathologies. For example, 
oral glutamine supplementation in healthy humans per-
forming moderate intensity exercise prevented the exer-
cise-induced increase in intestinal permeability [34], thus 
maintaining integrity of the intestinal - immune system 
during periods of elevated metabolism. 
Skeletal muscle is the major tissue that synthesizes 
glutamine by virtue of its mass in the body. The enzyme 
glutamine synthetase catalyzes the synthesis of glutamine 
from ammonia and glutamate. Mammalian skeletal mus-
cle comprises approximately 40% of lean body mass, and 
intramuscular glutamine serves as a regulator of the ana-
bolic state of this tissue. In nourished mammals, skeletal 
muscle releases glutamine into the circulation at a rate of 
40 - 60 mmol/h [32,35]. When dietary intake of glutamine is 
low (e.g., as a result of typical horse forage) circulating 
concentrations of glutamine are low, and about 13-60% of 
that found when dietary glutamine is high (Table 1). The 
circulatory system provides a means of transporting gluta-
mine to those cells that require it and that are not capable 
of synthesizing adequate amounts to meet their demands 
(Figure 1). 
The liver, like skeletal muscle, both synthesizes and 
consumes glutamine. The enzymes for each process are 
compartmentalized to different hepatic cell systems [30]. 
The liver normally produces a small amount of glutamine 
and plays a role in fine-tuning plasma [glutamine]. 
In the kidneys, glutamine serves as the major substrate 
for ammoniagenesis, the process of removing nitrogen 
from the body, and in whole-body acid-base balance [30]. 
The glomeruli filter glutamine, but it is nearly complete-
ly resorbed by the renal tubules. During extended periods 
of increased metabolism (prolonged exercise, physical 
training, pregnancy, lactation, some diseases, including 
some cancers) resulting in net whole-body catabolism, 
there is a large increase in immune and intestinal cellular 
glutamine utilization, as well as increased hepatic ex-
traction where glutamine is used for acute phase protein 
synthesis and glucose production. Exocrine signals act-
ing on skeletal muscle result in a net proteolysis within 
muscle cells and increased net glutamine synthesis. This 
is often accompanied by decreased intestinal glutamine 
utilization [30], with consequent impairment of intestinal 
and immune function [28].
Glutamine is converted to glutamate in the brain and 
serves important roles in neurotransmitter regulation. In 
particular, glutamate regulates the neurotransmitter gam-
ma-aminobutyric acid (GABA), which is required for 
brain functioning and mental activity. Glutamine newly 
synthesized from ammonia and glutamate by astrocytes 
within the brain is extracted by neurons. Enzymes then 
hydrolyze the intracellular glutamine back to glutamate, 
some of which is decarboxylated to produce GABA, or 
transaminated to aspartate [10].
Figure 1. An overview of the tissues involved in the 
synthesis, transport and metabolism of glutamine. Most 
circulating glutamine is produced by glutamine-synthesiz-
ing tissues. Within the small intestine, greater than 80% of 
glutamine is extracted by and metabolized by enterocytes. 
Very little ingested glutamine enters the general circula-
tion
Glutamine is essential for lymphocyte proliferation 
(which are unable to synthesize glutamine) and other rap-
idly dividing cells, such as gut mucosa and bone marrow 
(mesenchymal) stem cells; inadequate glutamine supply 
is associated with impaired function in these cellular sys-
tems [12,13,35]. High rates of leukocyte (particularly lympho-
cyte) glutamine extraction and utilization has led to the 
classification of glutamine as an immunostimulant. 
Glutamine serves as a metabolic precursor for other 
important amino acids such as arginine, citrulline and pro-
line. Within the intestinal system (splanchnic bed), unoxi-
dized glutamine and proline serve as important precursors 
for citrulline synthesis, which is then converted to arginine 
in the kidney [36]. Arginine is a semi-indispensable amino 
acid in neonates and serves numerous metabolic roles in 
young and adult mammals [3,12].
Glutamine also plays important roles in whole-body 
biochemical and energy regulation. For example, it serves 
as a substrate for several amidotransferases that synthesize 
purines, pyrimidines, NAD, glucosamine and asparagine 
[30,32]. Most of the body’s glutamine is hydrolyzed to glu-
tamate and ammonia via the action of glutaminase. Gluta-
mate can, in turn, be converted into glutathione, proline, 
ornithine and arginine, it can also be catalyzed to produce 
glucose, or it can be oxidized to produce ATP. The carbon 
is excreted as carbon dioxide and the nitrogen is excreted 
DOI: https://doi.org/10.30564/vsr.v2i1.1619
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as ammonia and urea.
Amino acids, through a large variety of inhibitory 
mechanisms and signaling pathways, act to regulate gene 
expression in numerous cell types within the body. Tran-
scription factors mediate these effects, including specific 
regulatory sequences, such as amino acid response ele-
ments that are sensitive to changes in amino acid concen-
tration [37]. In particular, glutamine, at appropriate concen-
trations, enhances numerous cell functions by activating 
various transcription factors. Some of the better-under-
stood functions include the inflammatory response, cell 
proliferation, cell differentiation and survival, and several 
metabolic functions.
In summary, Ruth and Field [38] identified the following 
metabolic functions for glutamine:
(1) serves as a precursor and energy substrate for im-
mune and epithelial cells;
(2) is important for intestinal development and function 
and for maintaining the integrity of the gut barrier, the 
structure of the intestinal mucosa, and redox homeostasis;
(3) supports proliferative rates and reduces enterocyte 
apoptosis;
(4) protects against pathogenic bacterial damage to in-
testinal structure and barrier function;
(5) lowers inflammatory response and increases im-
munoregulatory cytokine production; and improves the 
proliferative responses and numbers of intestinal immune 
cells.
2.1 The Small Intestine - Immune System Rela-
tionship
The present understanding of the intimate relationship 
between the gut (entire gastro-intestinal system) and the 
immune system has recently been presented by Ruth and 
Field [38] and Miron and Cristea [39]. There is considerable 
agreement amongst mammalian studies across species, 
and it is highly likely that the key elements observed in 
other mammals are transferable to horses:
(1) the intestine is the main site of nutrient absorption 
and amino acid metabolism, and the gut-associated lym-
phoid tissue (GALT) is also the largest immune system 
organ in the body. 
(2) the enterocytes play multiple roles with respect to 
immune function and maintenance of immune health, in-
cluding protection against oral pathogens, inducing oral 
tolerance to food stuffs, and maintaining a healthy interac-
tion with commensal bacteria.
(3) the enterocytes also maintain barrier function be-
tween luminal contents (external environment) and the 
internal environment of the body (also reference [40]). This 
barrier function is dependent on dietary glutamine avail-
ability (also reference [34]). 
(4) dietary amino acids (in particular, glutamine, glu-
tamate, arginine, and perhaps methionine, cysteine and 
threonine) are essential to optimize the enterocytes’ and 
intestinal immune cells’ immune functions (i.e., dendritic 
cells, beta cells, macrophages, T cells). Each has unique 
properties essential for maintaining the intestine’s integri-
ty, growth and function, and for regulating local tissue and 
organ immune responses. 
Glutamine supplementation has been shown to be ef-
fective in maintaining a normal intestinal barrier against 
pathogens and preserve mucosal integrity [8,34,38,39,41-43]. 
Using rodent models of intestinal mucosal obstruction and 
injury (similar to an equine obstructive small intestinal 
“colic”), glutamine supplementation prevented the large 
increases in intestinal permeability and bacterial translo-
cation seen in non-supplemented animals [42,43].
3. Are Horses Deficient in Glutamine?
Compared to other amino acids, the concentrations of 
glutamine are relatively high in plasma (0.30 - 2.0 mmol/
L depending on species and stage of development) and 
skeletal muscle (up to 3 mmol/L or approximately 60 
mmol/kg wet weight). These concentrations provide an 
indication of the importance of glutamine within the body. 
With low to normal amounts of dietary glutamine, up to 
100% of the glutamine ingested with protein is utilized by 
cells of the small intestine. In this typical situation, none 
of the dietary glutamine enters the systemic circulation 
[30]. Instead, plasma concentrations of glutamine are main-
tained by de novo synthesis from metabolic precursors. In 
this sense glutamine is considered to be non-essential.
In horses, the pre-feeding or fasting tissue glutamine 
concentrations reported in most studies (Table 1) are con-
siderably lower than those reported in well-fed, healthy 
humans [44] (500 - 700 µmol/L) and rats [45,46] (700 - 1,000 
µmol/L), and horses [47] (900 - 1,000 µmol/L). The fact 
that research horses receiving a near-optimum diet have 
average plasma [glutamine] ranging from 880 to 1,020 
µmol/L [47] lends further support to the theory that dietary 
glutamine may be physiologically limiting in many hors-
es.
3.1 Horses at Rest
In adult horses a number of studies published over a near-
ly 50-year period have reported an average plasma gluta-
mine concentration of about 300 µmol/L (Table 1). The 
lowest values appear to be 150 µmol/L [48] and the highest 
values about 1,000 µmol/L [47]. In foals peak values occur 
at 2 weeks, and decline to values seen in adults by time of 
DOI: https://doi.org/10.30564/vsr.v2i1.1619
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Table 1. Fasting or pre-feeding plasma and muscle glutamine concentrations in horses
Study Breed (number) Age Tissue Concentration1
Johnson and Hart 1974 [72] Mixed (12) adult Plasma 293 + 21
Rogers et al.
1984 [22] QH mares (10)
10 - 12 months gestation 





300 (12 w prepartum)
600 (1-2 d postpartum)
511 (3 w postpartum)
736 (3 w postpartum)
Russell et al.
1986 [73] QH (6) 22 months Plasma 15
2
Miller & Lawrence 1988 [64] QH (6) adult PlasmaPlasma
493 + 48 (low protein)
393 + 18 (high protein)
Miller-Graber et al. 1990 98 unknown (4) adult Muscle ~450 + 40
Jahn et al.
1991 [54] TB (24) 2 - 4 years Plasma 227 + 14
Duckworth et al. 1992 [75] Mixed (7) adult Plasma 572 + 24
Silver et al.
1994 [50] Pony mares (12)









1994 [25] Mixed (6)










King & Suleiman 1998 [69] TB (6) adult Plasma 367 + 19
Routledge et al. 1999 [53] Mixed (19) 6 - 12 years Plasma 470 + 15310 + 20
Robson et al. 2003 [55] Endurance traineda 9.4 + 2.2 years Plasma 279 + 16
Harris et al.







40 day trial 9 - 14 months Plasma
304 + 9 (start study)
345 + 15 (end study)
Hackl et al.
2009 [62] SB trotters (36) 2 - 10 years Plasma 385 + 16*
Manso Filho et al 2008 [18] SB (3) 1., 10 & 30 years Skeletal muscle 3,000 to 5,000





290 + 20, 7 w prepartum
510 + 20, parturition
290 + 15, 8 w postpart.
7,000 + 700 (all times)
Manso Filho et al. 2009 [20] SB (8) Mares at birth Amniotic fluidPlacenta
310 + 25
2,800 + 2,100
Urschel et al. 2010 [48] TB (6) 4 - 8 years Plasma 149 + 21155 + 20




403 (209 - 663)
1,800 + 1,100
2,500 + 1,200
Westermann et al. 2011 [61] SB (10) 20 + 2 months Plasma 392 + 62*
Nostell et al.
2012 [63] SB trotters (12) 4 - 9 years Plasma 255 + 30
Urschel et al. 2012 [47] Arabian (12) 9 - 22 years Plasma 1,060 + 60
Peters et al.
2013 [60] Warmblood mares (6) 12 + 3 years Plasma 281 + 40
Tanner et al.
2014 [16] Not stated (6) 6 mo weanlings Plasma 561 + 24





Mastellar et al. 2016 [97] TB (6) 1 year Plasma 223 + 42~1,000 + 110
Notes: Values are mean + standard error. 1 Plasma: µmol/L; Muscle, placenta: µmol/kg wet weight. 2 reported values in this pa-
per are 10-fold less than likely, which would make this ~150 µmol/L. * Significant decrease with exercise. QH = quarter 
horse; SB = Standardbred; TB = Thoroughbred.
DOI: https://doi.org/10.30564/vsr.v2i1.1619
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weaning [49]. Skeletal muscle [glutamine] is typically an 
order of magnitude greater than that of plasma, but also 
declines rapidly (within 1 month) in foals [49]. 
Manso Filho et al. [49] examined muscle and plasma 
[glutamine] during the first year of life in Standardbred 
foals. Glutamine was one of the most abundant free 
α-amino acids in skeletal muscle at birth. The concentra-
tion at 7 days declined by more than 50% by 6 months 
with no change thereafter. The initially high glutamine 
concentrations can in part be explained by provision of 
glutamine in mother’s milk, and occurring at a time of 
elevated glutamine synthesis in mares that doubles plas-
ma [glutamine] at the time of parturition [19,22] and mirrors 
elevated umbilical plasma vs maternal plasma [gluta-
mine] [25,50]. As solid foods are introduced and the horse is 
weaned, then plasma [glutamine] decreases to reflect the 
balance between tissue requirements (related to metabolic 
activity) and dietary intake. One interpretation is that low 
plasma glutamine concentrations reflects a high demand 
for glutamine, thus the prevalent plasma [glutamine] of 
~300 µmol/L may indicate a state of suboptimal glutamine 
synthesis and provision. 
The fact that so many equine studies report relatively 
low plasma glutamine concentrations, while there is ev-
idence that plasma glutamine in horses can be as high as 
normally seen in humans, raises the possibility of chronic 
hypoglutaminemia in the general horse population. It is 
proposed that a chronic hypoglutaminemia would be due 
to inadequate dietary supply of glutamine [2,27] combined 
with inadequate rates of endogenous glutamine synthesis 
from metabolic precursors. From these results it is con-
cluded that the low tissue glutamine concentrations report-
ed in most equine studies reflect typical equine diets that 
are low in dietary sources of glutamine such that dietary 
supplementation of glutamine may be appropriate.
3.2 Horses with Elevated Metabolic Needs
3.2.1 Pregnancy and Lactation
During pregnancy, the fetus extracts glutamine from the 
placental circulation [49] and umbilical [25] plasma [gluta-
mine] is more than double that of mares’ general circu-
lation [25]. There is a large increase (approx. doubling) of 
plasma [glutamine] between 2 weeks pre-partum and the 
first few days post-partum [22]. Lactation is also very meta-
bolically demanding period: the mammary glands extract 
glutamine during lactation and [glutamine] is abundant in 
the milk of lactating mares [19], although. After peaking at 
1 - 2 weeks of lactation, by 3 months of lactation in mares’ 
plasma and milk [glutamine] had decreased by more than 
50% which, together with loss of lean body mass, is indic-
ative of a mild catabolic state [49]. The authors concluded 
that the decrease in circulating [glutamine] during lacta-
tion, when large amounts of glutamine are being extracted 
by the mammary gland, “means that glutamine availabil-
ity for maternal organs, such as the small intestine and 
immune cells, may be limiting as lactation proceeds”.
Despite the capacity of key tissues, predominantly 
skeletal muscle, to synthesize glutamine, these data, 
though limited, suggest that increased dietary glutamine 
intake would be needed in order to maintain adequate (> 
500 µmol/L) plasma [glutamine]. Plasma [glutamine] av-
eraged 360 µmol/L pre-fasting in seven lactating mares, 
but fell to 247 µmol/L after 36 h of fasting and recovered 
to only 318 µmol/L 6 h after additional feeding [50]. While 
fetal plasma [glutamine] were nearly double those of 
their mares [22,49], the fetal plasma [glutamine] similarly 
decreased after fasting [22]. This, in part, reflects the high 
requirement of the developing fetus for glutamine, despite 
the high capacity of the placenta to synthesize glutamine 
[20]. 
Dietary composition also has pronounced effects on 
plasma glutamine concentrations in the transition (peripar-
tum through to beginning of lactation) mare; the dietary 
provision of even non-glutamine-containing supplements 
added to forage more than doubled plasma [glutamine] 
[22]. This provides evidence that the provision of other nu-
trients to glutamine-producing cells and tissues, increases 
the production and release of glutamine by these cells / 
tissues into the blood at a crucial time when glutamine is 
in high demand by other cells / tissues. It is also an indi-
cation that whole body glutamine demands have not been 
adequately met prior to provision of additional nutrients. 
In horses in a catabolic state, dietary supplementation of 
glutamine can help minimize or prevent the catabolic state 
and be used to maintain steady [glutamine] essential for 
intestinal and immune function and health [51].
Consistent with the equine studies cited above, Wu [52] 
considers dietary glutamine to be “substantially inade-
quate” to meet the requirements for protein synthesis in 
extra-intestinal tissues in growing pigs. By extension, this 
author infers that such is the case for mammals during 
periods of elevated metabolism (exercise, lactation, ac-
tive growth and development [27]). A typical diet does not 
provide sufficient arginine, proline, aspartate, glutamate, 
glutamine, or glycine for optimum protein accretion in 
growing pigs [52].
3.2.2 Exercise
Exercise, whether of long-term low intensity or short-term 
high intensity, imposes significant increases in cellular and 
whole body metabolism often associated with increased 
DOI: https://doi.org/10.30564/vsr.v2i1.1619
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skeletal muscle proteolysis [35,53]. As a result the intramus-
cular and plasma concentrations of some amino acids and 
ammonia increase. Plasma [glutamine] also rises in part 
as a result of proteolysis and in part due to an increased 
requirement to detoxify ammonia [54].
In horses, humans and rodents, moderate to high in-
tensity or duration exercise results in immune function 
suppression [35,55-57]. Exercise typically, but not always [54], 
depresses plasma glutamine [35,57], but this result also needs 
to be considered in the context of intensity of exercise and 
timing of post-exercising sampling. Glutamine supple-
mentation also enhances the immune response to intense 
exercise, effects that appear to be mediated by intestinal/
immune system interaction [35,58,59]. Glutamine supplemen-
tation prevents the increase in intestinal permeability that 
occurs during moderate intensity exercise [34]. Neutrophils, 
which comprise 50-60% of the total leukocyte count, elicit 
some of the beneficial effects seen with glutamine supple-
mentation [56]. 
Supplemented, exercise-conditioned rats performed 
one hour of exercise at 85% of peak VO2 
[56]. In one group 
of rats, glutamine was supplemented by oral gavage one 
hour before exercise. Compared to the control group that 
did not receive glutamine, the supplemented rats’ neutro-
phils had significantly increased phagocytic capacity. The 
supplemented rats also showed a smaller decrease in nitric 
oxide production than normally seen with intense exercise 
and higher production of reactive oxygen species.
In the equine hindlimb, glutamine appears not to be 
utilized by muscle as a fuel source during exercise [60] and 
only contributed to about 1.3% of the VO2 at rest. Post-ex-
ercise, average hindlimb venous plasma [glutamine] was 
slightly greater than arterial. This may indicate net synthe-
sis and release by muscle in order to meet glutamine de-
mand of other tissues in the body, but definitive research 
remains to be performed.
In horses performing a constant speed, 20-minute dura-
tion, high intensity (about 80% of peak VO2) exercise test 
[61], and with high-intensity maximal speed exercise [62], 
plasma [glutamine] decreased significantly immediately 
after exercise and did not recover. 
Horses performing a very high intensity (about 115% 
of peak VO2) exercise test had decreased plasma [gluta-
mine] 5 minutes after exercise, and a significant recovery 
peaking at 30 to 60 minutes, followed by a gradual de-
cline to typical post-prandial steady-state values [53]. These 
authors and Jahn et al. [54] attributed the post-exercise glu-
tamine increase to ammonia detoxification associated with 
the increased intramuscular ammonia production. Similar 
results were reported with horses completing high intensi-
ty field exercise testing [63].
The decrease in plasma [glutamine] associated with rel-
atively high intensity exercise contrasts with the increase 
seen by Jahn et al. [54] and during constant-speed moder-
ate-intensity exercise [64] and was of a magnitude similar 
to the osmotic loss of plasma fluid (decrease in plasma 
volume [65] suggesting no net addition or loss of glutamine 
during this type of exercise. Plasma [glutamine] returned 
gradually to pre-exercise values over a 30-minute period.
When Harris et al. [66] supplemented dietary glutamine 
(single feeding and 10 days of supplementation at 30 and 
60 mg/kg body mass; equal to about 15 and 30 grams, re-
spectively) in athletically-worked horses, they found that 
even this relatively low amount of supplementation nearly 
doubled plasma [glutamine]. They concluded that increas-
ing plasma [glutamine] through the diet has “benefit in the 
athletically worked horse with lowered plasma glutamine 
concentrations”. A recent study in horses supplemented 
with a dietary protein / amino acid mixture within the first 
hour of completing high intensity exercise concluded that 
supplementation directly after training decreases post-ex-
ercise skeletal muscle proteolysis [67]. 
When Matsui et al. [68] infused radio-labeled phenylala-
nine (for calculating amino acid kinetics in horse muscle) 
they showed that intravenous administration of an amino 
acid mixture shortly after heavy exercise decreased the 
rate of muscle proteolysis and increased the rate of pro-
tein synthesis in the hind limb. van den Hoven et al. [21] 
reported that oral administration of amino acids to horses 
within 1 hour after exercise increased the intramuscular 
amino acid concentrations. Using exercise trained horses, 
van den Hoven et al. [21] supplemented the diet with amino 
acids for 6 weeks. High intensity exercise resulted in a 
16% decrease in muscle [glutamine], followed by a 30% 
increase in muscle [glutamine] 4 hours after completion 
of exercise. This was associated with a 25% increase in 
post-exercise plasma [glutamine] when the amino acid 
supplement was offered during the first hour post-exer-
cise. By 18 hours after exercise, plasma and muscle values 
had returned to pre-exercise baseline values. Both of these 
studies indicate a benefit, if not a need, for supplementary 
dietary glutamine, as well as some other amino acids, as 
a result of exercise, even in horses receiving daily supple-
ments of amino acids.
Robson et al. [55] examined the effects of long-term en-
durance exercise (80 km endurance race) on plasma [glu-
tamine] and immune function parameters. Pre-race plasma 
[glutamine] were low (279 + 16 µmol/L). That there was 
no decrease immediately post-race, one hour post-race, 
and one-day and three-days post-race may be attributed to 
these very low starting values. In the post-race period, the 
horses experienced decreased neutrophil oxidative burst 
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activity and up to a three-fold decrease in circulating lym-
phocytes that was not fully recovered by three days post-
race (impaired immune response). In these athletic horses, 
it appears that low plasma [glutamine] contributed to the 
severity of the observed immune depression. The results 
also indicate that these endurance horses did not receive 
adequate dietary glutamine.
A 16-week, regular exercise training program for Thor-
oughbred horses [69], and 4 to 16-week training periods of 
varying intensities using Standardbred horses [61], had no 
effect on plasma [glutamine] pre- versus post-training, 
which remained between 300 and 500 µmol/L. There do 
not appear to be studies that have examined the effect of 
standard race-training programs on glutamine concentra-
tions and tissue stores.
A viral challenge (equine influenza virus) of six horses 
resulted in a gradual and progressive ~30% decrease in 
plasma [glutamine] over a six-day period, and [glutamine] 
remained depressed for at least an additional eight days 
[53]. The study authors attributed this result to an increased 
requirement for glutamine by immune system cells. A sus-
tained decrease in circulating [glutamine] was suggested 
to impair the horses’ ability to mount an effective immune 
response.
In summary, the evidence provided in this section indi-
cates that dietary glutamine, and perhaps other amino ac-
ids that influence tissue glutamine synthesis, are not pro-
vided in adequate amounts to maintain optimum health. 
Intestinal health and immune health appear to be the best 
studied with respect to deficiency of glutamine, but effects 
on other systems may come to light as research continues.
4. Dietary and Supplemented Glutamine
The main sources of glutamine in the equine diet are plant 
proteins from forage and from supplemented grains [14]. 
The crude protein (CP) content of forages ranges from 
very low - with timothy at about 8% and alfalfa as high 
as 25% [70,71]. For horses, there is no glutamine recom-
mended dietary allowance (RDA). The NRC [14] states that 
the daily protein requirement is 0.49 - 0.68 g /kg body 
mass (compared to 0.6 - 0.8 g/kg in humans). For horses 
in light to moderate work, this translates to 250 g of CP 
per day for a 450 kg horse, which provides up to 40 g of 
glutamine daily based on the typical proportions of amino 
acid in equine diets [14]. The recommendation increases to 
approximately 320 g CP/day for 450 kg horses in heavy 
work, which translates to 51 g of glutamine daily. A recent 
study using isotopically labeled amino acids compared 
two protein-supplemented diets in weanling horses, with 
horses receiving either 3.1 g or 4.1 g CP/kg body weight/
day [16]. Compared to horses receiving the lower amount of 
crude protein, horses receiving the higher amount of crude 
protein showed time-dependent increases in plasma amino 
acid concentrations, including glutamine, and that these 
horses had a higher rate of whole body net protein synthe-
sis. Tanner et al. [16] concluded that, in the lower CP group, 
provision of at least one amino acid potentially limited the 
rate at which protein synthesis occurred.
In horses, as with other animals that consume dietary 
protein, plasma amino acid concentrations depend on feed 
composition, time of blood sampling relative to meals 
and tissue amino acid turnover [24,66,72,73]. When Miller and 
Lawrence [64] fed diets containing 12.9% versus 18.5% 
crude protein for two weeks, plasma [glutamine] was 
actually greater on the control diet (493 + 18 µmol/L) 
compared to two weeks on the high protein diet (393 + 18 
µmol/L). While the amino acid profile of the diets had not 
been determined one interpretation of these results is that 
provision of additional amino acids in the high protein 
diet may have resulted in increased demand for glutamine 
or reduced synthesis of glutamine.
In response to the consumption of single meals, plas-
ma [glutamine] typically increases with a peak occurring 
three to five hours after feeding [22-24,53,73]. The increase in 
plasma [glutamine] can be explained by absorption of glu-
tamine into the blood from the intestinal system (mainly 
small intestine) and/or from de novo synthesis of gluta-
mine. This distinction must be made because studies that 
have directly examined intestinal glutamine transport have 
reported little to no glutamine entry into the circulation 
[74-76]. The lion’s share of intestinal (luminal) glutamine 
is taken up by enterocytes [76] and metabolized [74]. Of the 
glutamine that does enter the portal circulation, the portal 
drained viscera extracts about two-thirds of the circulating 
glutamine [75]. Thus ingested glutamine poorly accounts 
for the observed plasma glutamine concentrations. At 
stated by Manso Filho et al. [18] the great majority of glu-
tamine within the body of the horse must be synthesized 
de novo through the action of glutamine synthetase. This 
conclusion is supported by the inverse relationship be-
tween tissue glutamine concentration and glutamine syn-
thase protein expression in horses [18].
In the post-feeding period if food is withheld, then be-
tween 32 and 48 hours after feeding plasma [glutamine] 
rises somewhat for several hours [73]. This sustained el-
evation during the fasting period reflects release of syn-
thesized glutamine into the circulation and indicates the 
importance of maintaining elevated plasma [glutamine]. 
In all mammals, and, indeed, most vertebrates, the pri-
mary functions of the small intestine are to absorb both 
water and low molecular weight nutrients exiting from the 
stomach. These nutrients include mono- and di-saccha-
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rides (i.e. glucose, fructose), amino acids and dipeptides, 
free fatty acids, monovalent and divalent cations and 
anions (electrolytes), vitamins and trace minerals. These 
functions in the horse are similar to that of other mammals 
[77-82].
Many nutrients are transported into the blood by the 
intestinal system via the portal circulation (i.e., the blood 
supply to the liver from the intestinal system). In contrast, 
many amino acids enter the small intestine but do not en-
ter the portal circulation, and thus do not make their way 
to the rest of the body. The intestines use 20% of the ex-
tracted amino acids for intestinal mucosal protein synthe-
sis and the remainder for many other metabolic processes, 
including providing oxidative energy. For example, two-
thirds of the glutamine, one-third of the proline and nearly 
all of the glutamate and aspartate are catabolized within 
swine small intestines rather than absorbed into the cir-
culatory system [52]. Enterocytes are the major site of glu-
tamine extraction and oxidative ATP production, particu-
larly the absorptive columnar epithelial cells of the small 
intestine [30]. While one-third of glutamine not extracted 
by epithelial cells lining the intestinal lumen enters the 
portal circulation, cells of the small intestine also absorb 
some of this glutamine from the arterial circulation. This 
basal membrane route of glutamine entry into enterocytes 
appears to be important for the maintenance of gut health 
and immune function. In contrast to glutamine, most 
EAAs entering the small intestine are not extensively me-
tabolized within enterocytes.
Enterocytes along the length of the equine small in-
testine are well endowed with a variety of transporters 
for neutral (e.g. glutamine) and cationic amino acids [83], 
although there are some modest differences in the amino 
acid transporter rates and affinities between horses and 
omnivores [84]. The large capacity for glutamine transport 
results in the majority of ingested glutamine being trans-
ported into enterocytes along the entire length of the intes-
tinal system, with most of the uptake occurring from the 
small intestine [76,85]. 
Salloum et al. [76] studied the transport of glutamine 
into equine luminal enterocytes isolated from the jeju-
num. Similar to that of other mammals, the system B 
sodium-dependent transporter accounted for about 80% of 
the total transport. In a complementary study using anes-
thetized adult horses, Duckworth et al. [75] measured the 
capacity of the small intestine to extract glutamine from 
the arterial circulation. The extraction of glutamine by 
the equine jejunum in vivo more than doubled when the 
arterial concentration of glutamine was increased by bolus 
infusion, and jejunal extraction of glutamine was greater 
than that in the large intestine. 
5. Safety of Supplemented Glutamine
Only one peer-reviewed scientific study has examined 
safety of orally supplemented glutamine (very low 
amount) in horses and no adverse events were reported 
[86]. Therefore the peer-reviewed scientific literature on 
other species is used to provide an indication of safety in 
horses, keeping in mind the similarities between horses 
and other mammals with respect to small-intestinal and 
immune-system functions. The capacity of the intestinal 
system, skeletal muscle, liver and kidneys to extract glu-
tamine and glutamate is high, and Bertolo and Burrin [36] 
found that diets rich in glutamine or glutamate have little 
effect on circulating concentrations and low potential for 
toxicity.
In humans there is no defined Tolerable Upper Intake 
Level for dietary protein and 35% percent of total ener-
gy intake from protein is considered safe [87]. Within this 
context, and based on the absence of adverse effects, the 
Observed Safety Limit of glutamine supplementation (i.e., 
the highest amount one can consume that will not cause 
side effects) was identified to be 14 g/d (20 mg/kg body 
mass) in supplemental form above normal food intake in 
normal healthy adults [88]. This equates to 100 g/day for a 
500 kg horse. Higher dietary intake levels have been test-
ed in humans and shown to be well tolerated (for review 
see Wischmeyer [89], Watford [30]. In humans and other 
animals, ingestion of approximately 0.75 g glutamine/kg 
body mass (in the range of 40 - 60 grams per day) may 
increase plasma ammonia concentrations above the tol-
erated safety limit [90]. When orally supplemented below 
40 gram per day in humans (~0.5 g/kg body mass) no ad-
verse effects were reported [91,92]. Holecek [92] reported that 
intake levels of 40 grams or more consumed per day, glu-
tamine: (1) may impair amino acid transport and distribu-
tion among tissues because it competes with other amino 
acids for transport systems [76], such that individuals with 
reduced kidney function should carefully consider gluta-
mine requirements; (2) may impair synthesis of endoge-
nous glutamine and enhance glutamate and ammonia pro-
duction; (3) may impair ammonia detoxification; and (4) 
may result in an abnormal balance of amino acids in the 
body. Intake levels as high as 2.0 g/kg body mass in rats 
caused only an approximate 30% increase in brain striatal 
glutamine concentrations and only a 13% increase in stri-
atal fluid GABA concentrations [93]. Fifty human subjects 
aged 17 - 65 years old ingested a carbohydrate/glutamine 
(50 grams of glutamine) supplement less than 20 hours 
prior to elective bowel surgery and no adverse effects 
were observed. The authors concluded that this amount of 
acute glutamine supplementation was safe during pre-op-
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erative “fasting” and subsequent surgery [94]. Elderly men 
and women (69 + 8.8 years) ingesting 0.5 g/kg supple-
mental glutamine had no increase in plasma ammonia lev-
els, although these subjects did have increased serum urea 
and creatinine (within the normal range) that were deemed 
not clinically relevant [95]. In critically ill children, several 
studies have shown that glutamine supplementation was 
safe and did not cause toxic levels of ammonia or gluta-
mate that could be suggestive of neurotoxicity (reviewed 
by Albrecht et al. [29]. Single oral doses of glutamine of 
20 - 22 g/kg, 8 - 11 g/kg, and 19 g/kg were lethal in mice, 
rats, and rabbits, respectively [96].
Based on these data, and considering the relevant sim-
ilarities between species with respect to glutamine me-
tabolism, it can be concluded that supplementing dietary 
glutamine at up to 0.4 g/kg body mass above that provided 
in normal diets (13% crude protein) is safe for horses with 
healthy renal function in the long term. It is also indicated 
that short periods (one to two days) using dosages at high 
as 0.6 g/kg body mass may be safe when dealing with 
horses that have exceptionally high glutamine demands 
(late gestation, lactation, post-surgery, and after very 
stressful exercise or transport).
6. Summary and Conclusions
In summary, tissue glutamine concentrations are lower in 
most horses studied than in other mammals, reflecting diet 
composition, tissue glutamine requirements and possible 
dietary inadequacy. During normal periods of increased 
metabolic activity (lactation, growth and development of 
young, exercise and training), glutamine requirements are 
increased and glutamine availability appears to often not 
be adequate to meet requirements for optimum health. 
Dietary provision of glutamine has utility in minimizing 
or preventing catabolic states associated with periods of 
increased metabolic rate (exercise, lactation). Diets defi-
cient in glutamine do not provide sufficient glutamine to 
enterocytes and or other body systems. Dietary glutamine 
supplementation resulted in significant increases in horses’ 
systemic glutamine concentrations. Glutamine supplemen-
tation can help athletic horses increase plasma glutamine 
concentrations. All athletic horses tested have had low 
plasma glutamine concentrations, typically half that of 
well-fed healthy horses and healthy humans. A sustained 
decrease in plasma glutamine impairs a horse's ability to 
mount an effective immune response. During periods of 
inadequate dietary intake, inadequate tissue concentrations 
of glutamine are associated with impaired health, growth, 
development, intestinal function and immunity.
In conclusion, it is proposed that supplementary di-
etary glutamine will support intestinal cell nutrition, the 
immune system, and the general health of horses. Con-
sideration of the numerous benefits afforded by adequate 
dietary intake of glutamine has led to the animal feeds and 
supplements industries to develop, produce and market 
numerous glutamine-containing dietary supplements for 
horses, cattle, sheep, humans, swine, poultry and fish. 
As stated by Wu and coworkers [8,27,28,52] supplementing 
conventional diets with glutamine can optimize growth in 
young animals and help maintain health in animals and 
humans.
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